Assembly Biosciences, Inc. ASMB
20.42 USD +0.42 (+2.10%)
At closeNov 6, 2026, 4:00 PM EST
20.42 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
20.00 Day range 21.10
19.20 52-week range 39.71
- YTD
- -39.96%
- 1 year
- -34.57%
News
benzinga.com UBS Maintains Buy on Assembly Biosciences, Lowers Price Target to $48 UBS analyst Ashwani Verma maintains Assembly Biosciences (NASDAQ:ASMB) with a Buy and lowers the price target from $52 to $48.
globenewswire.com Assembly Biosciences to Participate in Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver…
benzinga.com Assembly Biosciences Doses First Two Patients In Its Phase 2 Clinical Trial Of ABI-6250 To Treat Chronic Hepatitis Delta Virus Infection Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced dosing of the first two participants…